» Articles » PMID: 21085181

2'-O Methylation of the Viral MRNA Cap Evades Host Restriction by IFIT Family Members

Abstract

Cellular messenger RNA (mRNA) of higher eukaryotes and many viral RNAs are methylated at the N-7 and 2'-O positions of the 5' guanosine cap by specific nuclear and cytoplasmic methyltransferases (MTases), respectively. Whereas N-7 methylation is essential for RNA translation and stability, the function of 2'-O methylation has remained uncertain since its discovery 35 years ago. Here we show that a West Nile virus (WNV) mutant (E218A) that lacks 2'-O MTase activity was attenuated in wild-type primary cells and mice but was pathogenic in the absence of type I interferon (IFN) signalling. 2'-O methylation of viral RNA did not affect IFN induction in WNV-infected fibroblasts but instead modulated the antiviral effects of IFN-induced proteins with tetratricopeptide repeats (IFIT), which are interferon-stimulated genes (ISGs) implicated in regulation of protein translation. Poxvirus and coronavirus mutants that lacked 2'-O MTase activity similarly showed enhanced sensitivity to the antiviral actions of IFN and, specifically, IFIT proteins. Our results demonstrate that the 2'-O methylation of the 5' cap of viral RNA functions to subvert innate host antiviral responses through escape of IFIT-mediated suppression, and suggest an evolutionary explanation for 2'-O methylation of cellular mRNA: to distinguish self from non-self RNA. Differential methylation of cytoplasmic RNA probably serves as an example for pattern recognition and restriction of propagation of foreign viral RNA in host cells.

Citing Articles

Animal Models, Therapeutics, and Vaccine Approaches to Emerging and Re-Emerging Flaviviruses.

Baric T, Reneer Z Viruses. 2025; 17(1).

PMID: 39861790 PMC: 11769264. DOI: 10.3390/v17010001.


Harnessing defective interfering particles and lipid nanoparticles for effective delivery of an anti-dengue virus RNA therapy.

Lin M, Maniam P, Li D, Tang B, Bishop C, Suhrbier A Mol Ther Nucleic Acids. 2025; 36(1):102424.

PMID: 39817192 PMC: 11733052. DOI: 10.1016/j.omtn.2024.102424.


RNA sensing at the crossroads of autoimmunity and autoinflammation.

Williams S, Sim S, Wolin S RNA. 2025; 31(3):369-381.

PMID: 39779213 PMC: 11874990. DOI: 10.1261/rna.080304.124.


CCR2 restricts IFN-γ production by hippocampal CD8 TRM cells that impair learning and memory during recovery from WNV encephalitis.

Ai S, Arutyunov A, Liu J, Hill J, Jiang X, Klein R J Neuroinflammation. 2024; 21(1):330.

PMID: 39725999 PMC: 11673327. DOI: 10.1186/s12974-024-03309-y.


Emerging prospects of mRNA cancer vaccines: mechanisms, formulations, and challenges in cancer immunotherapy.

Laila U, An W, Xu Z Front Immunol. 2024; 15:1448489.

PMID: 39654897 PMC: 11625737. DOI: 10.3389/fimmu.2024.1448489.


References
1.
Hui D, Bhasker C, Merrick W, Sen G . Viral stress-inducible protein p56 inhibits translation by blocking the interaction of eIF3 with the ternary complex eIF2.GTP.Met-tRNAi. J Biol Chem. 2003; 278(41):39477-82. DOI: 10.1074/jbc.M305038200. View

2.
Terenzi F, Hui D, Merrick W, Sen G . Distinct induction patterns and functions of two closely related interferon-inducible human genes, ISG54 and ISG56. J Biol Chem. 2006; 281(45):34064-71. DOI: 10.1074/jbc.M605771200. View

3.
Latner D, Thompson J, Gershon P, Storrs C, Condit R . The positive transcription elongation factor activity of the vaccinia virus J3 protein is independent from its (nucleoside-2'-O-) methyltransferase and poly(A) polymerase stimulatory functions. Virology. 2002; 301(1):64-80. DOI: 10.1006/viro.2002.1538. View

4.
Furuichi Y, Shatkin A . Viral and cellular mRNA capping: past and prospects. Adv Virus Res. 2000; 55:135-84. PMC: 7131690. DOI: 10.1016/s0065-3527(00)55003-9. View

5.
Wei C, Gershowitz A, Moss B . Methylated nucleotides block 5' terminus of HeLa cell messenger RNA. Cell. 1975; 4(4):379-86. DOI: 10.1016/0092-8674(75)90158-0. View